Appropriate antimicrobial treatment in nosocomial infections - the clinical challanges

被引:45
作者
Masterton, R [1 ]
Drusano, G
Paterson, DL
Park, G
机构
[1] Crosshouse Hosp, Ayrshire & Arran Acute Hosp NHS Trust, Kilmarnock KA2 0BE, Scotland
[2] Albany Med Ctr, Clin Res Inst, Div Clin Pharmacol, Albany, NY USA
[3] Univ Pittsburgh, Ctr Med, Dept Med, Div Infect Dis, Pittsburgh, PA USA
[4] Addenbrookes Hosp, Intens Care Unit, Cambridge, England
关键词
antibiotics; nosocomial infections; outcomes; drug therapy;
D O I
10.1016/S0195-6701(03)00294-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Resistance to antimicrobial agents is emerging in a wide variety of pathogens, particularly those that cause nosocomial infections. As a consequence of this increasing resistance, morbidity and mortality in nosocomial infections is also increasing. It is therefore critical to treat nosocomial infections appropriately by starting antimicrobial treatment early in the course of infection, using the correct agent, at the most appropriate dose, and for an adequate duration. Indeed early 'appropriate' antibiotic prescribing has been shown significantly to reduce mortality, Length of intensive care unit and hospital stay and overall costs. Early use of the correct antibiotic at the appropriate dose and for an adequate duration are key to initial appropriate antibiotic prescribing. Choosing the right antibiotic depends mainly on the likely pathogen(s) and the expected local susceptibility patterns. Selection of appropriate antimicrobial therapy requires a thorough understanding of the likely microbial cause of the infection, including local susceptibility patterns, as well as the properties of the antimicrobials available for treating these infections, namely spectrum of activity and potency (including activity versus known resistance mechanisms), pharmacokinetic profile and tolerability and safety. This review, based on a series of presentations at the 5th International Conference of the Hospital Infection Society (Edinburgh, 2002) examines the importance of appropriate antimicrobial therapy in nosocomial infections, and provides guidance on how to achieve this. (C) 2003 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
[31]  
Leibovici L, 1998, J INTERN MED, V244, P379
[32]   Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia [J].
Lerma, FA .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (01) :70-81
[33]   Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes [J].
Lucas, GM ;
Lechtzin, N ;
Puryear, DW ;
Yau, LL ;
Flexner, CW ;
Moore, RD .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1127-1133
[34]   Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia [J].
Luna, CM ;
Vujacich, P ;
Niederman, MS ;
Vay, C ;
Gherardi, C ;
Matera, J ;
Jolly, EC .
CHEST, 1997, 111 (03) :676-685
[35]   STUDY OF ANTI-MICROBIAL MISUSE IN A UNIVERSITY HOSPITAL [J].
MAKI, DG ;
SCHUNA, AA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1978, 275 (03) :271-282
[36]   Surveillance studies: how can they help the management of infection? [J].
Masterton, RG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 :53-58
[37]  
Masterton RG, 2002, J ANTIMICROB CHEMOTH, V49, p218A
[38]   Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy [J].
Montravers, P ;
Gauzit, R ;
Muller, C ;
Marmuse, JP ;
Fichelle, A ;
Desmonts, JM .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :486-494
[39]   Antibiotic resistance surveillance: action for international studies [J].
Morris, AK ;
Masterton, RG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) :7-10
[40]   MONITORING AMINOGLYCOSIDE THERAPY [J].
MULLINS, RE ;
LAMPASONA, V ;
CONN, RB .
CLINICS IN LABORATORY MEDICINE, 1987, 7 (03) :513-529